Fig. 5. Effects of MYR administration on locomotor activity in the OFT during SD. MYR, myricetin; OFT, open-field test; SAL, saline; WPF, wide platform; ATI, alprazolam.

Korean J Physiol Pharmacol 2022;26:415-425 https://doi.org/10.4196/kjpp.2022.26.6.415

© Korean J Physiol Pharmacol